Filing Flows

Filing Flows › Rapport Therapeutics (RAPP) › How it makes money

How Rapport Therapeutics (RAPP) makes money

Rapport Therapeutics (RAPP) made $20.0M of revenue in the first quarter 2026 (Q1 2026).

Drawing the Sankey…

Where each dollar of revenue goes

LineQ1 2026% of revenue
Revenue$20.0M100.0%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q1 2026$20.0M—

From Rapport Therapeutics' 10-Q filed May 7, 2026 (on EDGAR).

Questions

How does Rapport Therapeutics make money?

Rapport Therapeutics (RAPP) made $20.0M of revenue in the first quarter 2026 (Q1 2026).

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.